Table 2.
IRA stability in whole brain of CD-1 mice
| Whole Brain | Olfactory Bulb | Serum | ||||
|---|---|---|---|---|---|---|
| Single | AP% | Pcon % | AP% | Pcon % | AP% | Pcon % |
| Exenatide | 70.2 ± 17.7 | 88.2 | 55.2 ± 0.5 | 91.1 | 55.1 ± 11.9 | 81.4 |
| Semaglutide | 74.7 ± 17.7 | 98.7 ± 0.0 | 100.9 ± 0.5 | 98.3 ± 0.1 | 86.9 ± 1.1 | 98.9 ± 0.1 |
| Dual | AP% | Pcon% | AP% | Pcon % | AP% | Pcon % |
| DA4-JC | 171.1 ± 6.2 | 53.4 ± 2.3 | 59.4 ± 38.7 | 56.7 ± 0.6 | 190.0 ± 6.5 | 43.7 ± 2.6 |
| DA5-CH | 51.0 ± 6.1 | 97.7 ± 2.0 | 82.8 ± 8.1 | 70.3 ± 1.5 | 42.5 ± 1.9 | 90.1 ± 0.6 |
Acid precipitation (AP%) means ± SEM 30 min after IN administration of 125I/14C-IRAs in the whole brain (WB), olfactory bulb (OB), and serum (Ser). Data are expressed relative to processing controls (Pcon %, n = 2), which assesses stability due to processing only. Exenatide n = 3 M, semaglutide n = 2 M/2F, DA4-JC n = 3 M/3F, DA5-CH n = 4 M/4F. M = male, F = female